CLINICAL_TRIALS
trial_result
· 2020-12-09
Clinical Trial Update: A Study of LY3023414 and Necitumumab in Squamous Lung Cancer [Phase 2]
Summary
Phase 2 study of LY3023414 and necitumumab in metastatic non-small cell lung cancer was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Non-small Cell Lung Cancer Metastatic | Phase 2 | Status: TERMINATED | Results posted: 2020-12-09